CD274 and neoplasm: From June 2013 through December 2017, 102 mUC patients received PD-1/PD-L1 inhibitors at our institution and 67 of these patients had targeted next-generation tumour sequencing (Oncopanel) analysis performed on a primary or metastatic specimen.